|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
EBOOKCENTRAL_on1048776639 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
180811s2018 nju o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d AU@
|d OCLCQ
|d OCLCF
|d OCLCO
|d OCLCQ
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 1048287913
|a 1049605935
|a 1099792337
|
| 020 |
|
|
|a 9783527802760
|
| 020 |
|
|
|a 3527802762
|
| 020 |
|
|
|z 3527341625
|
| 020 |
|
|
|z 9783527341627
|
| 029 |
1 |
|
|a AU@
|b 000065115826
|
| 035 |
|
|
|a (OCoLC)1048776639
|z (OCoLC)1048287913
|z (OCoLC)1049605935
|z (OCoLC)1099792337
|
| 050 |
|
4 |
|a TP248.2
|b .M654 2018
|
| 082 |
0 |
4 |
|a 660.6
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Yamamoto, Hisashi.
|
| 245 |
1 |
0 |
|a Molecular Technology :
|b Life Innovation.
|
| 260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2018.
|
| 300 |
|
|
|a 1 online resource (402 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Title Page; Copyright; Contents; Foreword by Dr Hamaguchi; Foreword by Dr Noyori; Preface; Chapter 1 Control of DNA Packaging by Block Catiomers for Systemic Gene Delivery System; 1.1 Introduction; 1.2 Packaging of pDNA by Block Catiomers; 1.2.1 Rod-Shaped Packaging of pDNA; 1.2.2 Rod Shape or Globular Shape; 1.3 Polyplex Micelles as a Systemic Gene Delivery System; 1.3.1 Stable Encapsulation of pDNA Within Polyplex Micelles for Systemic Delivery; 1.3.2 Polyplex Micelles for Efficient Cellular Entry; 1.3.3 Polyplex Micelles for Safe Endosome Escape.
|
| 505 |
8 |
|
|a 1.3.4 Polyplex Micelles for Nuclear Translocation1.3.5 Polyplex Micelles for Efficient Transcription; 1.4 Design Criteria of Block Catiomers Toward Systemic Gene Therapy; 1.5 Rod Shape or Toroid Shape; 1.6 Summary; References; Chapter 2 Manipulation of Molecular Architecture with DNA; 2.1 Introduction; 2.2 Molecular Structure of DNA; 2.3 Immobile DNA Junctions; 2.4 Topologically Unique DNA Molecules; 2.5 DNA Tiles and Their Assemblies; 2.6 DNA Origami; 2.7 DNA Origami as a Molecular Peg Board; 2.8 Molecular Machines Made of DNA Origami; 2.9 DNA Origami Pinching Devices.
|
| 505 |
8 |
|
|a 2.10 Novel Design Principles2.11 DNA-PAINT: An Application of DNA Devices; 2.12 Prospects; References; Chapter 3 Chemical Assembly Lines for Skeletally Diverse Indole Alkaloids; 3.1 Introduction; 3.2 Macmillan's Collective Total Synthesis by Means of Organocascade Catalysis; 3.3 Systematic Synthesis of Indole Alkaloids Employing Cyclopentene Intermediates by the Zhu Group; 3.4 Biogenetically Inspired Synthesis Employing a Multipotent Intermediate by the Oguri Group; References; Chapter 4 Molecular Technology for Injured Brain Regeneration; 4.1 Introduction; 4.2 Biology of Angiogenesis.
|
| 505 |
8 |
|
|a 4.3 Angiogenesis for Injured Brain Regeneration4.4 Molecular Technology to Promote Angiogenesis; 4.5 Biology of Cell Cycle; 4.6 Biology of Neurogenesis; 4.7 Molecular Technology to Promote Neuron Regeneration; 4.8 Conclusion; References; Chapter 5 Engineering the Ribosomal Translation System to Introduce Non-proteinogenic Amino Acids into Peptides; 5.1 Introduction; 5.2 Decoding the Genetic Code; 5.3 Aminoacylation of tRNA by Aminoacyl-tRNA Synthetases; 5.4 Methods for Preparing Noncanonical Aminoacyl-tRNAs; 5.4.1 Ligation of Aminoacyl-pdCpA Dinucleotide with tRNA Lacking the 32 Terminal CA.
|
| 505 |
8 |
|
|a 5.4.2 Post-aminoacylation Modification of Aminoacyl-tRNA5.4.3 Misacylation of Non-proteinogenic Amino Acids by ARSs; 5.4.4 Flexizyme, an Aminoacylation Ribozyme; 5.5 Methods for Assigning Non-proteinogenic Amino Acids to the Genetic Code; 5.5.1 The Nonsense Codon Method; 5.5.2 Genetic Code Reprogramming; 5.5.3 The Four-base Codon Method; 5.5.4 The Nonstandard Base Method; 5.6 Limitation of the Incorporation of Noncanonical Amino Acids: Substrate Scope; 5.7 Improvement of the Substrate Tolerance of Ribosomal Translation.
|
| 500 |
|
|
|a 5.8 Ribosomally Synthesized Noncanonical Peptides as Drug Discovery Platforms.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
|
0 |
|a Nanotechnology
|x Research.
|
| 650 |
|
2 |
|a Biotechnology
|
| 650 |
|
6 |
|a Biotechnologie.
|
| 650 |
|
7 |
|a bioengineering.
|2 aat
|
| 650 |
|
7 |
|a Biotechnology
|2 fast
|
| 650 |
|
7 |
|a Nanotechnology
|x Research
|2 fast
|
| 700 |
1 |
|
|a Kato, Takashi.
|
| 758 |
|
|
|i has work:
|a Volume 1 Molecular technology (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFwWwPhFRbDRXTkkhBKDFX
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Yamamoto, Hisashi.
|t Molecular Technology : Life Innovation.
|d Newark : John Wiley & Sons, Incorporated, ©2018
|z 9783527341627
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5485649
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5485649
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 16209390
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 15631809
|
| 994 |
|
|
|a 92
|b IZTAP
|
